Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

D.Western Therapeutics Institute Inc

+ Add to Watchlist

6DW:GR

5.548 EUR 0.085 1.56%

As of 02:11:46 ET on 03/05/2015.

Snapshot for D.Western Therapeutics Institute Inc (6DW)

Open: 5.528 Day's Range: 5.528 - 5.599 Volume: 0
Previous Close: 5.463 52wk Range: 3.888 - 1,000.000 1-Yr Rtn: +42.70%

Stock Chart for 6DW

No chart data available.
  • 6DW:GR 5.599
  • 1D
  • 1M
  • 1Y
5.463
Interactive 6DW Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 6DW

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (12/2015) -
Est. PEG Ratio -
Market Cap (M EUR) 126.32
Shares Outstanding (M) 22.77
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 6DW

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 6DW

D.Western Therapeutics Institute Inc.(DWTI) is a biotechnology (bio-venture) company that focuses on development of new drugs. The Company's focus is on protein kinase inhibitors. DWTI discovers and develops several drugs, such as antiglaucoma, antihypertensive, neuroprotective, antithrombogenic, antiatherosclerosis and anticancer.

Hiroyoshi HidakaChairman/Chief Scientist OfcrYuichi HidakaPresident/CEO
Tetsuya KawakamiDirector
More Company Profile & Key Executives for 6DW

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil